RecruitingNot ApplicableNCT06103669

Locally AblatiVe TherApy in OLigO-pRogressive SOlid TUmorS (VALOROUS)


Sponsor

University of California, Davis

Enrollment

250 participants

Start Date

Oct 5, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This is a phase 2 pragmatic study that evaluates the clinical benefit of continuing systemic therapy with the addition of locally ablative therapies for oligo-progressive solid tumors as the primary objective. The primary outcome measure is the time to treatment failure (defined as time to change in systemic failure or permanent discontinuation of therapy) following locally ablative therapy.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This trial (VALOROUS) is studying whether targeted local treatments — such as radiation, ablation, or other focused therapies — can help people whose cancer has started growing in just a few spots even while they are on systemic treatment. It includes several cancer types including breast, gynecological, head and neck, and sarcoma. **You may be eligible if...** - You are 18 or older - You have a confirmed solid tumor (breast, gynecological, head and neck, sarcoma, or other) - You are currently on systemic therapy (e.g., chemotherapy or immunotherapy) and your overall disease is mostly stable - You have 5 or fewer spots of cancer that are newly growing or progressing - Those progressing spots can be safely targeted with local therapy (radiation or ablation) - You have had at least 1 prior line of systemic therapy with at least 3 months of benefit **You may NOT be eligible if...** - Your overall health prevents you from safely receiving local ablative therapy - You have had prior treatment side effects that rule out ablative treatment - You have cancer growing in the brain Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEAblative local therapy

Stereotactic ablative radiotherapy (SABR) or interventional radiology (IR) ablation therapy


Locations(1)

University of California, Davis

Sacramento, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06103669


Related Trials